Airflow obstruction, lung function, and risk of incident heart failure: The Atherosclerosis Risk in Communities (ARIC) study

European Journal of Heart Failure

Volumn 14, Issue 4, 2012, Pages 414-422

  Agarwal, Sunil K ^a   Heiss, Gerardo ^a   Barr, R Graham ^b   Chang, Patricia P ^a   Loehr, Laura R ^a   Chambless, Lloyd E ^a   Shahar, Eyal ^c   Kitzman, Dalane W ^d   Rosamond, Wayne D ^a  

^a IL   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cohort study; COPD; Heart failure; Lung function; Risk factors

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMMUNITY ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH CERTIFICATE; EMPHYSEMA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HAZARD RATIO; HEART FAILURE; HEIGHT; HUMAN; INCIDENCE; INFLAMMATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SPIROMETRY; UNITED STATES; VITAL CAPACITY;

COMORBIDITY; CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; LUNG; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; SELF REPORT;

EID: 84859037554     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfs016     Document Type: Article

References (35)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.
2. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276.
3. Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW. Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J Heart Fail 2006;8:706-711.
4. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005;127:1952-1959.
5. Yilmaz R, Gencer M, Ceylan E, Demirbag R. Impact of chronic obstructive pulmonary disease with pulmonary hypertension on both left ventricular systolic and diastolic performance. J Am Soc Echocardiogr 2005;18:873-881.
6. Funk GC, Lang I, Schenk P, Valipour A, Hartl S, Burghuber OC. Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure. Chest 2008;133:1354-1359.
7. Sabit R, Bolton C, Edwards J, Edwards P, Cockcroft J, Fraser A, Shale D. Subclinical bi-ventricular dysfunction in chronic obstructive pulmonary disease (COPD). Thorax 2007;62(Supplement 3):142.
8. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut SM, Kronmal RA, Lima JA, Shahar E, Smith LJ, Watson KE. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010; 362:217-227.
9. Engstrom G, Melander O, Hedblad B. Population-based study of lung function and incidence of heart failure hospitalisations. Thorax 2010;65:633-638.
10. Georgiopoulou VV, Kalogeropoulos AP, Psaty BM, Rodondi N, Bauer DC, Butler AB, Koster A, Smith AL, Harris TB, Newman AB, Kritchevsky SB, Butler J. Lung function and risk for heart failure among older adults: the Health ABC Study. Am J Med 2011;124:334-341.
11. Lam CS, Lyass A, Kraigher-Krainer E, Massaro JM, Lee DS, Ho JE, Levy D, Redfield MM, Pieske BM, Benjamin EJ, Vasan RS. Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation 2011;124:24-30.
12. Standardization of spirometry-1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987;136:1285-1298.
13. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978;118:1-120.
14. Vollmer WM, Johnson LR, McCamant LE, Buist AS. Methodologic issues in the analysis of lung function data. J Chronic Dis 1987;40:1013-1023.
15. Robins J. The control of confounding by intermediate variables. Stat Med 1989;8: 679-701.
16. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, Gardin JM, Rutledge JE, Boineau RC. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000;35: 1628-1637.
17. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005;128:2068-2075.
18. Kannel WB, Seidman JM, Fercho W, Castelli WP. Vital capacity and congestive heart failure. The Framingham study. Circulation 1974;49:1160-1166.
19. Kannel WB, Hubert H, Lew EA. Vital capacity as a predictor of cardiovascular disease: the Framingham study. Am Heart J 1983;105:311-315.
20. Enright PL, Kronmal RA, Smith VE, Gardin JM, Schenker MB, Manolio TA. Reduced vital capacity in elderly persons with hypertension, coronary heart disease, or left ventricular hypertrophy. The Cardiovascular Health Study. Chest 1995;107:28-35.
21. Olson TP, Beck KC, Johnson JB, Johnson BD. Competition for intrathoracic space reduces lung capacity in patients with chronic heart failure: a radiographic study. Chest 2006;130:164-171.
22. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165-1185.
23. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
24. Schroeder EB,Welch VL, Evans GW, Heiss G. Impaired lung function and subclinical atherosclerosis. The ARIC Study. Atherosclerosis 2005;180:367-373.
25. Han MK, McLaughlin VV, Criner GJ, Martinez FJ. Pulmonary diseases and the heart. Circulation 2007;116:2992-3005.
26. Vonk-Noordegraaf A, Marcus JT, Holverda S, Roseboom B, Postmus PE. Early changes of cardiac structure and function in COPD patients with mild hypoxemia. Chest 2005;127:1898-903.
27. Vonk Noordegraaf A, Marcus JT, Roseboom B, Postmus PE, Faes TJ, de Vries PM. The effect of right ventricular hypertrophy on left ventricular ejection fraction in pulmonary emphysema. Chest 1997;112:640-645.
28. Simpson JA, Brunt KR, Collier CP, Iscoe S. Hyperinflation-induced cardiorespiratory failure in rats. J Appl Physiol 2009;107:275-282.
29. Rodriguez-Roisin R, MacNee W. Pathophysiology of chronic obstructive pulmonary disease. Eur Respir Monogr 2006;38:177.
30. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 2009;11:130-139.
31. Lee DS, Donovan L, Austin PC, Gong Y, Liu PP, Rouleau JL, Tu JV. Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care 2005;43:182-188.
32. Goff DC Jr, Pandey DK, Chan FA, Ortiz C, Nichaman MZ. Congestive heart failure in the United States: is there more than meets the I(CD code)? The Corpus Christi Heart Project. Arch Intern Med 2000;160:197-202.
33. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000;161:381-390.
34. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007;175:458-463.
35. Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, Hoes AW. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005;26:1887-1894.